(Q45394339)

14 December 2017

title

Antidiabetic activity of gossypin, a pentahydroxyflavone glucoside, in streptozotocin-induced experimental diabetes in rats (English)

1 reference

14 December 2017

author name string

Thamizhiniyan Venkatesan

series ordinal

1

1 reference

14 December 2017

Subramanian Sorimuthu Pillai

series ordinal

2

1 reference

14 December 2017

publication date

1 March 2012

1 reference

14 December 2017

1 reference

14 December 2017

volume

4

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

41-46

1 reference

Diagnosis and Classification of Diabetes Mellitus

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

21 January 2018

Oral Antidiabetic Agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

The biochemistry and medical significance of the flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Oral supplementation of gossypin during lead exposure protects alteration in heme synthesis pathway and brain oxidative stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Gossypin up-regulates LDL receptor through activation of ERK pathway: a signaling mechanism for the hypocholesterolemic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Comparative evaluation of some flavonoids and tocopherol acetate against the systemic toxicity induced by sulphur mustard

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

A new colorimetric method for the estimation of glycosylated hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Distribution of labelled streptozotocin in mice: uptake and retention in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Skeletal muscle metabolism in the pathology and treatment of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Role of oxidative stress in pancreatic beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Utility of hemoglobin A1c in predicting diabetes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1753-0407.2011.00145.X

10.1111/J.1753-0407.2011.00145.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference